Yalcin Baltali
Director, Resource Optimization, Novartis
Yalcin is leading Resource Optimization initiatives focused on maximizing the impact of IM US investments for Novartis IHD and CV Portfolio of Brands. Prior to Novartis, Yalcin has worked in BMS where was leading US Commercial Analytics covering the CV portfolio. He was acting as a strategic thought partner to cross-functional stakeholders solving key business questions. He has a broad range of pharmaceutical marketing and sales business acumen as well as strong analytical proficiency via academic knowledge and training. He is a seasoned professional with experience in conducting various statistical models in commercial effectiveness to help to determine the optimal (portfolio) budget allocation. He also has experience providing solutions for AI/ML based approaches for Next-Best-Action type of platforms, targeting & segmentation, sales force analytics, forecasting, and market research. Prior to BMS, Yalcin worked at Boehringer Ingelheim (BI) & Pfizer in the pharmaceutical space. He started his career at IMS Health (IQVIA) in healthcare consulting.
Yalcin recently graduated from his Executive Master in Consulting & Coaching for Change at INSEAD. He received his MBA from Temple University and completed his MS in Applied Statistics from Purdue University, Indianapolis. Yalcin also has a BA degree in Mathematics from METU, Turkey. He is also an adjunct faculty associate at Columbia University teaching strategy and analytics.
Bharath Bommakanti
Data Science Manager, Compile
Bharath is a Data Science Manager at Compile. He creates AI / ML approaches for real-world data
augmentation and insight generation. He has worked in healthcare analytics for 6+ years during which he
has addressed a variety of commercial healthcare problems.
Christel Chehoud, PhD
Senior Director, Global Commercial Data Science, Janssen Pharmaceutical Companies of Johnson & Johnson
Christel Chehoud, PhD, is a Senior Director within the Global Commercial Data Science at Janssen Pharmaceutical Companies of Johnson & Johnson. In this role, Christel focuses on the advancement and acceleration of global go-to-market strategies for product pipeline by developing end-to-end data science solutions for a wide range of commercial applications including healthcare provider customer targeting, omnichannel marketing, forecasting and real-world-evidence studies. Previously, within Janssen R&D, she led a team of data scientists delivering advanced analytics patient-level prediction models, clinical trial optimization, and biomarker identification. Christel holds a PhD from the University of Pennsylvania and AB in Molecular Biology and Computer Science from Princeton University
Kevin Coltin
Manager, Deloitte Consulting
Kevin works on applying advanced analytical methods to challenging problems in life sciences and healthcare, such as improving medication adherence, optimizing sales call planning and messaging, clinical trials, and safety reporting. He has experience building statistical models in R and Python, and has worked with linear models, decision trees, cluster analysis, classification methods, data visualization, and other mathematical and statistical methods. Some of his recent work in commercial analytics includes measuring the effectiveness of sales calls using causal inference methodologies, and using clustering models to understand the market in advance of a product launch. In R&D and safety, he has worked on building natural language processing models for identifying adverse events, and using predictive models for risk-based clinical trial monitoring. Kevin has a master’s degree in mathematics and a bachelor’s degree in mathematics and economics.
Abhisek Dash
Senior Product Manager, Compile
Abhisek is a Senior Product Manager at Compile, where he is responsible for building next-gen
affiliations, provider profiling, and real-world claims data assets. In his career spanning 7+ years, he has
helped many pharma and healthcare companies plan and realize their data strategy and analytics
journey.
Chad Dau
Vice President - Decision Analytics and Optimization, Lilly
Innovative global analytics leader with a history of creating strategies across pharmaceuticals, biotech, digital therapeutics, and consumer products. Developer of high-performing, diverse analytics and technology teams capable of bridging complex methods with business applications. Cross-functional leader that has helped bring teams together to launch over twelve products across immunology, oncology, rare disease, and digital therapeutics.
Bennett Davidson
Senior Manager, Pfizer
Bennett Davidson is a Senior Manager in the Business Analytics and Insights Group at Pfizer, supporting Paxlovid in the United States. As part of his work, Bennett leads primary market research efforts for the US HCP Commercial and Medical teams. Bennett also works in a cross-functional pod to deliver advanced insights and analytics to solve unique challenges that the Paxlovid team faces. Prior to working at Pfizer, Bennett spent over 5 years as an external consultant with PwC and Huron Life Sciences (now Oliver Wyman) and earned his MBA from Duke University.
Cindie Dilley
Global Head of Advanced Analytics, UCB
Cindie Dilley is the Global Head of Advanced Analytics at UCB, with direct responsibility for a 25-person multinational team of data scientists and data experts which create substantial business impact and strive to evolve our long term vision to enable our strategy to 2033.
Cindie has been in the pharmaceutical industry for over 20 years with a wide range of responsibilities on both the analytics and brand management parts of the business. Most recently she was the global strategy/brand head for both Staccato Alprazolam (currently in phase 3 development) and Briviact. She has also served operationally as the US Mission Head of Integrated Care in Neurology. Analytically, she has lead US Neurology Analytics and Market Research and has held a number of roles in sales analytics, forecasting, pricing and market research. Cindie received her MS in economics (and ABD in PhD) from the University of Illinois with a focus on International Finance and Development Economics.
Ralica Dimitrova, PhD
Senior Data Scientist, IQVIA
Dr. Ralica Dimitrova is a Senior Data Scientist at IQVIA with 10 years of experience in medical and healthcare research. She leverages supervised and unsupervised machine learning tools to help clients gain deeper insights into complex diseases and identify opportunities to improve patient outcomes. Prior to joining IQVIA, Ralica utilized statistical modelling to develop innovative tools that capture the enormous clinical heterogeneity in early brain development, promoting the implementation of personalized clinical management strategies for vulnerable infants. Ralica holds a PhD and post-doctoral training in Neonatal Brain Development and Image Analysis from King's College London.
Simon Fitall
CEO, Tudor Health
Simon has been an active member of the international life science insights community for 30 years. Through his experiences in patient data capture, analysis, modeling, and forecasting, Simon brings a novel perspective to being CEO of Tudor Health. Simon has been working in the patient-level data space for 25 years, building complex data analytics and exploration tools, as well as helping to design the creative data capture and business models now employed by Tudor Health. Simon has a BSc in Business Management from Western Governor’s University.
Suman Giri
Global Head of Commercial Data Science & Analytics, Merck
Suman Giri is the global head of commercial data science and analytics within Merck’s Human Health Division. He is passionate about designing responsible ML-systems and solutions that are built for scale and with end-user experience in mind. Suman has spent the majority of his career in various data-science leadership roles within the US Healthcare eco-system. He holds a PhD from Carnegie Mellon University.
Michael Golub
Global Director of Data Science Research, Operations and Innovation
Michael leads the Data Science Research Operations and Innovation team responsible for developing internal AI products and rapid insights within the Merch Human Health Organization. Prior to Merck, Michael has taken multiple data science teams from incubation to mature delivery organizations. He has over 20 years of experience in Digital Analytics and Enterprise Application Development with a focus on applied Machine Learning. Michael is also a public speaker on the topic of Ethical AI and sits on the Data Science Industry Advisory boards for Drexel and DeSales Universities.
Paul Gurney, Ph.D.
Vice President of Data Product, Komodo Health
Paul Gurney is the Vice President of Data Product at Komodo Health, responsible for driving development of the Healthcare Map. Before Komodo Health, Paul spent 15 years working on Commercial and R&D projects with Life Sciences companies as a Partner at McKinsey & Company. He holds a Ph.D. In Electrical Engineering from Stanford University.
Ira Haimowitz, PhD
VP, Product Management, Deloitte Consulting LLP
Ira Haimowitz, Ph.D. is Vice President of Product Management at Deloitte Consulting, developing and delivering strategy and analytics solutions for the life science industry. He combines AI and machine learning education from MIT and Cambridge University with over 20 years of product leadership and consulting expertise. Prior to joining Deloitte, Ira drove product development and delivery at analytics consultants and agencies. Ira has also led client-side marketing and sales analytics teams at Pfizer, Organon, and General Electric Research. He is a Past President and Board Member of the Pharmaceutical Management Science Association.
Yan Hu, PhD
Associate Director - Data Science, Novo Nordisk
Yan Hu is a PhD in Computer Science, she has a strong foundation in the technical aspects of AI/ML techniques, which she applies to develop predictive and forecasting models for a variety of projects.
As an Associate Director of the Advanced Analytics and Innovation team at Novo Nordisk Inc., Yan is responsible for overseeing the development and implementation of data-driven solutions to support the company's healthcare operations. Her expertise in predictive and forecasting modelling has proven valuable in projects such as sales forecasting, patient finding, and HCP targeting and segmentation for commercial operations.
Yan's work in the healthcare industry for more than 5 years demonstrates her commitment to applying her skills and knowledge to improve patient outcomes and support the success of healthcare companies. Her expertise in AI/ML techniques allows her to develop data-driven solutions that can help healthcare organizations make more informed decisions and achieve their business objectives.
Yuhan Jao, PhD
Associate Director of Decision Sciences, Sunovion Pharmaceuticals
Yuhan Jao is the Associate Director of Decision Sciences at Sunovion Pharmaceuticals. Her work at Sunovion is to develop analytical solutions to inform sales force targeting, sizing, omnichannel marketing, and performance measurement with statistical and machine learning modeling. She has a PhD in Social Sciences and a MS in Statistics from Northwestern University with over 6 years of experiences in data sciences across different industries.
Ashutosh Katiyar
Senior Director - Commercial Insights & Analytics, Ophthalmology Commercial Strategy, Regeneron Healthcare Solutions
Ashutosh is the Head of Commercial Insights and Analytics, Ophthalmology at Regeneron Pharmaceu-ticals, NY. He has 18+ years of experience in bio-pharma/healthcare space delivering business in-sights, leading data science , marketing mix model-ing, forecasting, & commercial analytics across US / Global. In his current role at Regeneron, Ashutosh is responsible for building strategic business insights, brand growth opportunity assessments and omni-channel capabilities. Prior to joining Regeneron, Ashutosh held various US and Global commercial strategy and analytics roles at Amgen, Shire and ZS associates (Business Consulting).
Ashutosh holds Masters in Marketing from Kelley School of Business, Indiana University as well as another Masters in Manufacturing Systems Engi-neering from University of Wisconsin-Madison. He did his Bachelors in Mechanical Engineering from IIT Roorkee, India.
Devika Kaushal
Senior Data Scientist, Novo Nordisk
Devika Kaushal joined Novo Nordisk as a Senior Data Scientist in the Advanced Analytics team with Commercial Insights and Analytics (CI&A). She supports the most relied-on and complex analytical processes within CI&A. She has been responsible for (1) determining the response to promotions across various marketing channels and providing data-driven inputs for budget optimization across these channels, (2) evaluating the effectiveness of individual point-in-time marketing campaigns, and (3) identifying optimal targets for digital marketing. At Novo, she has led an effort to internalize and streamline various impact assessment methodologies. She focuses on improving measurement accuracy, experimenting with new approaches, and setting up efficient and replicable processes for re-running critical analyses. She is also a Computer Engineer and MBA with 9+ years of work experience in training and consulting.
Ewa J. Kleczyk, PhD, SVP
Analytics & Data Operations, Target RWE
Ewa J. Kleczyk, PhD is a Senior Vice President of Commercial Analytics & Data Curation at Target RWE that provides best-in healthcare industry real-world data (RWD) solutions utilized throughout the drug development and commercialization spectrum. Previously, she was a Vice President of Advanced and Custom Analytics at Symphony Health, ICON, plc.
Dr. Kleczyk is also a highly sought-after conference speaker and author who has published in multiple academic & industry journals, contributed chapters to several academic books as well as has been a board member of several peer-reviewed publications.
Dr. Kleczyk has been an active advocate of mentoring future women leaders of the healthcare industry for which she has been recognized with multiple leadership awards, including HBA’s ‘Rising Star’ & ‘Luminary’ recognitions. Along with her husband, James Strout, she is also a Board Member on the Community Cancer Council for the Northern Light Health Network in Bangor, ME. that provides advocacy for cancer patients, and a graduate faculty in the School of Economics at the University of Maine, Orono, ME.
Dr. Kleczyk earned her Doctorate Degree in Agricultural & Applied Economics from Virginia Tech, Blacksburg, VA. She is originally from Wroclaw, Poland.
Hemant Kumar
Director Lead - Resource Optimization (Data Science), Novartis
Hemant has been with Novartis for over 10 years with his current role as the Director lead, Resource Allocation and Optimization for US Pharma Brands. Prior to this, Hemant was leading Kesimpta & S1P Commercial Analytics in Neuroscience. In his prior roles, Hemant was instrumental in driving IPMMs for US Pharma Brands, Portfolio Optimization Solutions and Analytics for Kesimpta launch, Performance Measurement & deep data insights to enable decision making.
In addition, Hemant brings with him a rich background in Data Science, RWE Predictive Modeling, Marketing Mix Modeling & Digital Analytics during his tenure at Novartis. Hemant lives in Parsippany, NJ near the East Hanover site and in his spare time loves being outdoors, hiking & exploration.
Hemant holds Masters & Bachelors degrees in Biochemical Engineering and Biotechnology from Indian Institute of Technology Delhi.
Shubham Kumar
Manager, Deloitte Consulting
Shubham is a Strategy & Analytics Manager in Deloitte’s Life Sciences practice. With a background in advanced analytics, Shubham often serves as a quantitative strategist, working at the intersection of commercial strategy and data science teams to generate customer insights and drive growth opportunities. She has experience driving customer-centered engagement and commercial analytics for a number of large pharmaceutical and biotech clients. Shubham has a BS in Engineering and an MBA from Chicago Booth.
Ruoxin Li
Senior Director, Data Science and Advanced Analytics, IQVIA
Ruoxin Li is currently a Senior Director, Data Science and Advanced Analytics at IQVIA. Ruoxin has over 15 years of experience in applying data science techniques to the pharmaceutical industry. His first PMSA attendance dates back to 2008. He has been with IQVIA since 2019. Prior to joining IQVIA, Ruoxin had worked on both client and consulting sides with experience in supporting successful launches and boosting performance of inline brands. Ruoxin is leading a team of analytics experts and machine learning professionals to provide data-driven solution to pharma clients. He is a business leader with an MBA from UC Berkeley, and also a passionate physicist with a PhD from Yale. Ruoxin’s interests span a wide range of things, including big data, AIML, math and physics, music, and sports.
Alice Liang
Senior Director, Decision Sciences, Sunovion Pharamaceuticals
Alice Liang is the Senior Director of Decision Sciences at Sunovion Pharmaceuticals, leading advanced analytics, omnichannel customer marketing analytics, market access analytics and commercial reporting. With 15+ years of experience building analytical solutions in the pharma industry, she has recently expanded her role to lead the commercial reporting function. She received her MS in Biostatistics from Yale University.
Javier Lopez-Molina, MBA, MS, BA
Senior Director, Medical Strategy, IQVIA
Trained as a molecular biologist and developmental biologist, Javier leads IQVIA’s US Medical Affairs Strategy team. He partners with life science companies to leverage real world data to drive improved patient outcomes. He has worked with teams to build an RWE platform in Europe that analyzed healthcare practices and patient outcomes in lung cancer. As part of that initiative, he worked side by side with patient advocacy group representatives to incorporate the patient voice into the design of real world evidence studies. He has also partnered with teams to incorporate RWD into innovative clinical trial designs. During the pandemic, he managed content creation for the weekly thought leadership report: “Monitoring the Impact of COVID-19 on the Pharmaceutical Market,” which was awarded the 2021 IQVIA CEO Award.
Rohit Marwah
Associate Principal, Definitive Healthcare
Rohit Marwah in his dual role is a subject matter expert and real-world data specialist on Commercial and HEOR analytics and is the product head of the Passport Analytics Platform. He has 15 years of experience leading advanced data analytic projects and defining commercial strategies using real-world data. Rohit has helped pharma and payer clients solve complex challenges in data curation and insights generation using descriptive, prescriptive, and predictive methodologies. Rohit has a Master of Engineering in Biotechnology and Bioinformatics and data science certification from Harvard.
Xiaoyang Meng, PhD
Data Scientist, Janssen North America Business Technology, Commercial Data Science, Janssen Pharmaceutical Companies of Johnson & Johnson
Xiaoyang Meng, Ph.D., is a Data Scientist from Commercial Data Science, North America Business Technology at Janssen Pharmaceutical Companies of Johnson & Johnson. In his role, Xiaoyang focuses on leveraging predictive modeling with machine learning and advanced algorithms to serve patients through omnichannel initiatives, global pricing strategies, and real-world evidence studies. Xiaoyang holds a Ph.D. in Environmental Engineering and M.S. in Computer Science and Engineering from Georgia Institute of Technology.
Kate Mulroney
Senior Director, Novo Nordisk
Kate leads the Advanced Analytics & Innovation function for Novo Nordisk’s US affiliate, which is a team of data scientists responsible for the application of advanced analytical methods and capabilities across the Commercial and Enabling functions. They partner cross-functionally to deliver business value via data mining, statistical analysis, predictive and prescriptive analytics, AI/ML and data visualization. Area of work include marketing investment analytics, A/B testing, patient & HCP finding, patient journey, segmentation and targeting, and Next Best Action analytics. Kate has been with Novo Nordisk over 19 years in both business and IT roles, in the US and Denmark, where she established the initial “big data analytics” capabilities, combining cloud architecture, open-source tools, and AI/ML techniques. She holds a bachelor’s degree in Operations Research from MIT and an MBA from Harvard Business School.
Surya Pandruvada
EVP Pharmaceutical Practice, Ipsos MMA
Surya leads Ipsos MMA’s pharmaceutical and healthcare practice and is based out of the New York office. At Ipsos MMA he has played the lead role in shaping innovative analytic solutions enabling pharma companies to launch products effectively through optimal go-to-market strategies, understand the market dynamics and opportunities through mar-ket structure analysis, and improve sales and mar-keting effectiveness and efficiency through unified commercial measurement by combining top down commercial mix with bottoms-up HCP/patient level attribution.
Surya’s proven ability to develop creative and inno-vative solutions that materially improve marketing effectiveness have been extremely valuable to his client partners. His ability to work closely and collab-oratively at each step in the process has resulted in long-term, sustainable adoption of the Ipsos MMA Unified Marketing Measurement capabilities and so-lution. Prior to re-joining MMA in 2022 where he had spent almost 6 years previously, Surya held roles of escalating responsibility at BD (a global medical technology company), Novartis and Merkle.
Surya is an Advisory Board Member at Seton Hall University and holds an MBA in Business Admin-istration from the University of Arizona, Eller College of Management. He also holds a Bachelor of Engi-neering, Mechanical from the Government College of Engineering in Karad.
Patrick Peristeri, MA, MBA
Director - International Analytics & Forecasting, HorizonTherapeutics
Patrick set up the Forecasting and Analytics function for Horizon in the EMEA-Canada region. He has over 18 years of experience in the Pharma business. Prior to Horizon, Patrick worked for Amgen and Janssen, leading forecasting, market research and competitive intelligence projects for various franchises, notably oncology and immunology across the EMEA region.
Armand Prieditis, PhD
Senior Director of Data Science, ICON
Dr. Prieditis has been building large-scale data science systems for over 20 years. He is currently a Sr. Director of Data Science at Symphony. Prior to that, he was Head of R&D at the Center of Excellence in Data Science at Cigna, where he built prediction systems for multiple verticals (customer & clinical, provider, client, and pharmacy) based on diagnosis and treatment codes, laboratory results, and demographics. Before this, he built an award-winning prescription fraud detection system for a Silicon Valley startup, was a Chief Data Scientist for a fintech startup, and developed machine learning systems for DNS anomaly detection, router geo-location, and movie recommendations for Neustar as a Principal Scientist/Distinguished Engineer. Earlier still, he ran two machine learning companies (one on search recommendations and the other on factory automation) and was a professor of Computer Science at the University of California-Davis. Armand’s Ph.D. in Computer Science (Machine Learning) is from Rutgers University. He holds twelve patents and has numerous publications in leading AI and Machine Learning journals.
Andres Quintero, MD, MPH, MBA
Medical Director, Global Medical Affairs, Pfizer
Andres Quintero is a physician board certified in Public Health and Preventive Medicine. He’s a Global Medical Affairs director for Pfizer’s hospital and internal medicine unit, where he leads the glu-cocorticoid portfolio.
Dr. Quintero relies on data and meta-data to inform strategic and operational decision making for organ-izations at various levels of leadership. He delivers systems-based solutions through structured problem solving that offers quantitative rigor and qualitative perspective, emphasizing defensible, practical and actionable solutions that emerge from data infer-ences.
After over a decade of adopting analytics, he’s iden-tified many challenges in this ecosystem that are served well by representing the proper mix of skill-sets in all analytics endeavors. Experts with pro-grammatic skills to access and manipulate large da-tasets are no doubt front and center to these en-deavors. What is often missing, however, is the proper medical and epidemiological subject matter expertise which is critical for proper context and methodological oversight. As an early adopter of ad-vanced analytics within Pfizer’s medical affairs func-tion, Dr. Quintero advocates assertively for the rep-resentation of these three skillsets as part of stew-ardship for responsible analytics.
Dr. Quintero is passionate about approaching medi-cine and decision making as probabilistic endeav-ors; about recognizing the many tradeoffs at play with various types of data; and proceeding with data-driven endeavors despite those limitations when the next best alternative is to make decisions in the ab-sence of empirical information.
Daniela Rosales
Senior Manager, Pfizer
Part of the Business Analytics and Insights' Data Science team, Daniela has been involved in multiple projects that look to advance Pfizer into a data-driven model. Through collaboration with internal and external partners, she has implemented innovative segmentation exercises, informed marketing strategies, and measured key outputs for commercial efforts.
With over five years of experience in the industry prior to Pfizer, she came from a consulting background working in IQVIA doing multiple projects for Mexico and Latin America. She has a B.Sc. in Biotechnology from Instituto Tecnologico y de Estudios Superiores de Monterrey.
Sameer Sardana
Head of Product, Axtria
Sameer is Head of Product at Axtria and leads the CustomerIQTM, MarketingIQTM, and InsightsMAxTM product lines. Sameer is responsible for using the power of world-class software products to drive data and analytics driven customer experience personalization and marketing effectiveness for life sciences customers. He is also responsible for driving Axtria’s product strategy, roadmap, and customer success. Prior to Axtria, Sameer was at Cognizant Analytics where he was responsible for a portfolio of pharma and biotech clients. Sameer holds a Bachelor’s degree in Chemical Engineering and a Master’s degree in Process Engineering and Design from Indian Institute of Technology, Delhi.
Troy Sarich
Chief Global Commercial Data Science Officer at Johnson & Johnson
Troy has worked in global pharmaceutical R&D and Commercial businesses for the past 25 years. He has led teams for major drug programs and has expertise in clinical development, data science, RWE, digital health, precision medicine, launches, market access, start-up models and major business transformations across multiple therapeutic areas. He is a recipient of the prestigious Johnson Medal Award as part of the XARELTO® team effort to bring this innovative medicine to millions of patients around the world. He continues to build and lead high-performing teams dedicated to improving the lives of patients.
As Chief Commercial Data Science Officer, Janssen Pharmaceuticals, Troy is responsible for accelerating the global expansion of industry-leading commercial Data, Data Science, RWE, Precision Medicine and Digital Health capabilities for Janssen in order to drive the growth for our $50+ Billion worldwide commercial pharmaceutical business. He partners with our commercial, technology and R&D leaders across the globe to build future-facing teams and capabilities and to advance go-to-market strategies. He believes we are on the verge of realizing the true potential of advanced analytics, machine learning and AI solutions to have a direct impact on millions of patients and to provide a key differentiator to business growth in the coming years.
Arya Sarkar
Director - Data Strategy, Novartis
Arya Sarkar is the Director of Data Capabilities primarily focusing on US Oncology and Precision Medicine at Novartis. As a part of his role, he leads strategy development for overall commercial market data. Arya Joined Novartis in 2019 and has since held various positions within Commercial Analytics and Data Strategy. He has a Master’s Degree in Engineering Management from Case Western Reserve University and a Bachelor’s Degree In Mechanical Engineering.
Lutz Schlicht, PhD
Chief Commercial Officer, Target RWE
Lutz Schlicht, PhD is the Chief Commercial Officer of Target RWE. He has 20+ years of experience in the Biopharmaceutical Industry, 15+ years of these in senior/executive marketing and sales positions in different countries and healthcare systems. In the US he led AbbVie’s domestic HIV, Dermatology and HCV franchises and launched as global lead blockbusters such as Skyrizi. With the introduction of the Humira ambassadors he changed the industry’s care offering for patients. Lutz holds a PHD from the University of Cologne, Germany in Physical Chemistry/Theoretical Physics.
Sagar Shah
Head, Pharma Practice & Responsible AI, fractal.ai
As Head of Responsible AI & Head of Pharma Practice at Fractal, consulted Fortune 500 C-suite in Pharma and Consumer Goods to drive 100MN+ impact. Industry-noted thought leader in Bloomberg, Forbes, Fortune; Advisory with India Govt and NASSCOM (100+ conferences, white-papers, articles). Lead Fractal Dimension, an inter-disciplinary team of AI, Engineering and Design to solve complex problems. Expertise in marketing analytics, integrated business planning, visualization, ecommerce. Researched at IIT Bombay, University of Karlsruhe, National Center for Biological Sciences and Tata Institute of Fundamental Research.
Laura Shapland
Chief Executive Officer, CareSet
As the Chief Executive Officer, Laura plays a pivotal role in defining CareSet's vision and aligning the team to execute the go-to-market strategy. Prior to her current role, she served as Chief Operating Officer at 2nd.MD (acquired by Accolade), where she successfully oversaw the growth of the company from ideation to servicing Fortune 500 firms. Laura holds a Bachelor's degree from Rice University and an MBA with High Honors from the University of Chicago Booth School of Business. In her personal life, she indulges in a wide range of interests, spends quality time with her three daughters, and enjoys playing fetch with her Aussiedoodle dog named Doc.
Mehul Singh
Associate Partner, ZS Associates
Mehul is an Associate Partner with ZS’ Princeton office and is a leader in ZS’ AI practice. Mehul has designed and delivered several AI based products in APAC, EU, and North America to inform commercial strategy decisions for Pharmaceutical Manufacturers and Health Plans. Mehul’s primary area of interest is data driven resource allocation and precision engagement for providers, patients, and payers. Prior to joining ZS, Mehul worked on AI applications in Consumer-Packaged Goods, and Energy Industries.
Vishwadeep Singh
Senior Director, ciPARTHENON Solutions, CustomerInsights.AI
Vishwadeep is the Senior Director, ciPARTHENON Solutions at CustomerInsights.ai. He has 18+ years of experience in life sciences commercial operations, digital transformation initiatives, marketing operations, product strategy, commercial data engineering and analytics.
Vishwadeep has global experience (US/Ex US) leading engagements for top life sciences organizations that includes, designing & developing information management strategy, supporting sales force operations, institutionalizing the digital data hubs for brand marketing, establishing the global framework for harmonizing the data, reporting & analytics, conceptualizing the model for taxonomy standardization across marketing tactics & campaigns.
Ricky Smith
Director, Commercial Access, Dermavant Sciences, Inc.
Ricky is the Director of Commercial Access a Dermavant Sciences, Inc. He has 18+ years of experience in commercial, trade, marketing and sales analytics, patient access, forecasting, marketing mix modeling, and global supply chain management.
Relevant experience
Ricky has spent the last decade of his career in the healthcare industry building various analytics teams from the ground up. Incorporating new datasets, implementing best in class processes, and pioneering award-winning patient access solutions across several disease states.
Rich Sokolosky
CEO & Co-Founder, Sentier Analytics
Rich has spent his entire career in data and analytics, starting with building data warehouses and integrating business intelligence tools at AMS and MicroStrategy. He then moved to strategically identifying and applying emerging big data and analytics technologies to pressing life science questions at Shyft, Humedica, and NewVantage. As the field continues to evolve, he believes there has never been more opportunity to generate significant value from the creative application of industry knowledge, new data sources, and advanced analytics.
Lukasz Sowinski
Senior Manager Data Science, Blend 360
Lukasz Sowinski is a senior manager of data science at Blend360. His work primary work at Blend360 includes leading the measurement practice.
Jeremy Stamer
Lead, New Products and BD&L, Novartis
Jeremy is the New Products and BD&L team lead, supporting pipeline commercialization efforts for Novartis. Prior to joining Novartis, Jeremy worked for IQVIA, providing insights and analytics from enriched longitudinal patient data platforms for large pharma clients. Additionally, Jeremy has served in leadership roles in Portfolio Management, Market Research, Forecasting, Insights, and Sales Operations functions.
Karl Svensson
Senior Director, Data Science and Advanced Analytics, Horizon Therapeutics
Karl Svensson is a seasoned analytics leader focused on solving complex business problems with data. Over his healthcare-focused career, Karl has experience in AI/ML, forecasting, data engineering, insights generation, and marketing effectiveness. Currently he is the Senior Director of Data Science and Advanced Analytics at Horizon Therapeutics. Karl holds a Bachelor’s degree in Economics from Northwestern University, and a Master’s degree in Predictive Analytics from DePaul University.
Patrice Tankpinou
Director, Advanced Analytics, Sanofi
Patrice Tankpinou, MScPA is a Director of Advanced Analytics - Omnichannel AI solutions at Sanofi, a leader in the pharmaceutical industry. He has 20-years of experience across the fields of Advanced Analytics AI & ML, Global Business & Marketing. His experience spans various industries, CPG & Retail, Banking, Insurance, Food, Oil & Gas, Technology & Telecommunications, Pharmaceutical, Manufacturing, working both as a consultant and in-house.
Although he is now focusing on realizing the promises of AI in the Omnichannel Pharma Marketing, he remains passionate and committed to continuing to evolve AI capabilities as they apply to driving business results, within the constraints of AI Ethics – an aspect of the profession he takes very seriously.
Patrice holds a Master of Science in Predictive Analytics from Northwestern University, and a Bachelor of Arts in Business & Global Marketing from Muhlenberg College.
John K. Thompson
Global Head of Artificial Intelligence, Ernst & Young
John is an international technology executive with over 35 years of experience in the fields of data, advanced analytics, and artificial intelligence (AI). He is currently the Global Head of AI at EY.
John has been responsible for the global advanced analytics and AI function at a leading biopharmaceutical company where he led a team that developed and deployed over 25 analytical applications in 4 years. John was an Executive Partner at Gartner, where he was management consultant to market leading companies in the areas of digital transformation, data monetization and advanced analytics. Before Gartner, John was responsible for the advanced analytics business unit of the Dell Software Group.
John’s new book – Data for All, has been written for the general public, the book is an outline of how the world of data works today and how it will work in the near future. Described as a “Revolutionary Manifesto for Data”, the book instructs people in how to protect and manage their data and the data of their loved ones. Data for All communicates how to do this in applied and practical terms.
John is the author of the bestselling book – Building Analytics Teams: Leveraging analytics and artificial intelligence for business improvement. The book was published in June 2020 and outlines how to hire and manage high performance advanced analytics teams. The book outlines how to engage with executives and senior managers. How to select and undertake analytics projects that change and improve how a business operates.
John is co-author of the bestselling book – Analytics: How to win with Intelligence, which debuted on Amazon as the #1 new book in Analytics in 2017. Analytics is a book that guides non-technical executives through the journey of creating an analytics function, funding initiatives, and driving change in business operations through data and applied analytical applications.
Mr. Thompson’s technology expertise includes all aspects of advanced analytics and information management including – descriptive, predictive and prescriptive analytics, artificial intelligence, analytical applications, deep learning, cognitive computing, big data, simulation, optimization, synthetic data, and high-performance computing.
JP Tsang, PhD, MBA (INSEAD)
President, Bayser
Jean-Patrick Tsang is the Founder and President of Bayser, a Chicago-based consulting firm dedicated to sales and marketing for pharmaceutical companies. JP is an expert in data strategy and advanced analytics. JP has published 25+ papers, given 80+ talks at conferences, and completed 250+ projects. In a previous life, JP deployed Artificial Intelligence to automate the design of payloads for satellites. JP earned a Ph.D. in Artificial Intelligence from Grenoble University, advised 2 PhD students, and earned an MBA from INSEAD in Fontainebleau, France. He was the recipient of the 2015 PMSA Lifetime Achievement Award.
Vladimir Tsutskhvashvili
Sr. Director of Product Management, Genentech
Vladimir has more than 20 years of experience in the biotechnology and finance industries, focusing on driving revenue, building customer loyalty, and streamlining the business tools and processes. For the past 5 years, he has been leading the strategic initiatives in the Medical Affairs space, helping to make a shift towards the patient-centric mentality by applying ML and predictive analytics to improve productivity, efficiency, and patient experience in Clinical Trial and Patient Safety areas. He has a Bachelor's degree in Integrative Biology from UC Berkeley and a Master's from the University of San Francisco.
Rohit Vashisht
Co-Founder & CEO, WhizAI
Rohit Vashisht is the co-founder and CEO of WhizAI, the Cognitive Insights Platform for Life Sciences. He has over 20 years of experience in enterprise software sales, product management, development, and strategy. As a tech entrepreneur, Rohit has built successful businesses and was CEO and co-founder of Sverve – an influencer marketplace that was acquired by Bloglovin and rebranded as Activate. At Sverve, he led the revenue growth and development of a self-serve platform connecting brands and influencers for marketing campaigns. At Activate, he spearheaded product, sales, and marketing strategy to grow the influencer marketing business.
A seasoned tech entrepreneur, he founded a fintech startup, held leadership roles at an enterprise software startup that grew to a $30M business, and executed profitable strategies at Vista Equity Partners’ product management group. Rohit holds an M.B.A from the NYU Stern School of Business and an engineering degree from I.I.T, Delhi. When Rohit is not in front of his laptop, he can be seen reading non-fiction, playing cricket and golf, or speaking at industry events.
Claudia Vesel, MS
Data Scientist II, Data Science & Advanced Analytics, Horizon Therapeutics
As a data scientist II for Horizon Therapeutics, Claudia Vesel has a proven record of utilizing data-driven insights to inform critical business decisions, and propel positive impact in healthcare. With modeling experience spanning physician targeting, market segmentation, and lead generation, Claudia leveraged medical-claims analyses in both commercial applications, as well as medical research. She holds a Bachelor's degree in Neuroscience and Bioengineering, and a Master's degree in Bioengineering from the University of Illinois at Chicago.
Olivia VonNieda
Head of Customer Success, Compile
Olivia brings her expertise in life sciences analytics to Compile as Head of Customer Success. Prior to Compile, Olivia worked for ZS Associates where she engaged on projects in pharmaceutical targeting, segmentation, alignments, and forecasting. As Forecasting Manager at AstraZeneca, Olivia was part of the launch team for Lynparza, a prescription medicine for ovarian cancer, where she focused on insights, analytics, and forecasting. Additionally, Olivia kick-started the Patient Disease Awareness Program at Edwards Lifesciences.
Olivia earned a BS in Industrial Engineering at Rensselaer Polytechnic Institute and an MBA at Harvard Business School.
Ketan Walia
Senior Manager, Axtria
Ketan is a Senior Manager, Data Science at Axtria Inc. He has over 8 years of experience in machine learning and data science domain. He has worked extensively on providing analytical solutions facilitating strategic decision making to companies in pharma, IT, and the automobile domain. He has significant industry experience is building Recommendation engines, Next Best Action frameworks, Casual Inference based decision making strategies. He also has research experience in developing NLP models for deciphering patterns in unstructured data. He graduated with a Master’s in Data Science from Rutgers University and holds a Bachelor’s in Electrical Engineering.
David Wood, PhD
Senior Principal, Axtria
David has more than 40 years of experience in mathematical modeling of business problems, with over 25 years in sales and marketing analysis for life sciences companies. At Axtria, David serves as a Senior Principal, with emphasis on projects in mathematical modeling of sales operations, multi-channel promotion analysis, and NBA modeling. David has also done substantial work in the development of Yield Management for the commercial airline industry, and has worked in finance, energy, and natural resource economics issues. His education includes BS, MS, and PhD degrees in Engineering and Operations Research, all from UC Berkeley.
Glen Ye
Director, New Products and BD&L, Novartis
Glen is a Director with the New Products and BD&L team at Novartis. He serves as the analytics and insights lead for Novartis’s external pipeline assessment team. His pharma experience spans projects across Sales, Marketing, Go-to-Market Strategy, Market Expansion, and Growth, Operational Planning, Organizational Design, Portfolio Management, and Customer Experience.
